Health Canada authorized the Company’s protocol amendment that expands eligibility to include patients aged 12 and older with stage four…
WALTHAM, Mass. and BOULDER, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on…
AUSTIN, Texas, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics…
Event will focus on tavapadon, a D1/D5 partial agonist in Phase 3 development for the treatment of Parkinson’s disease Live…
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the "Company"), announced…
ORMOND BEACH, FL / ACCESSWIRE / November 28, 2023 / Health Information Sharing and Analysis Center (Health-ISAC), a global, Member-driven…
TORONTO, ON / ACCESSWIRE / November 28, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), is a…
Professor Claudio L. A. Bassetti, MD, is the Chair, Neurology Department, Inselspital, Bern University Hospital and Dean, Medical Faculty, University…
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as…
BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing novel precision therapeutics for central nervous system…